Implementation of ICH E9 (R1): a few points learned during the COVID-19 pandemic
Yongming Qu, Ilya Lipkovich

TL;DR
This paper discusses how the COVID-19 pandemic challenges clinical trial estimands, proposing improved strategies for handling intercurrent events using causal inference, to better align statistical analysis with clinical objectives.
Contribution
It introduces a refined framework for applying ICH E9 (R1) estimands, emphasizing differential handling of intercurrent events and the use of hypothetical strategies during disruptions like a pandemic.
Findings
Proposes a mix of strategies for handling ICEs based on reasons.
Suggests prioritizing hypothetical strategies for ICEs.
Provides a roadmap for estimation and sensitivity analyses.
Abstract
The current COVID-19 pandemic poses numerous challenges for ongoing clinical trials and provides a stress-testing environment for the existing principles and practice of estimands in clinical trials. The pandemic may increase the rate of intercurrent events (ICEs) and missing values, spurring a great deal of discussion on amending protocols and statistical analysis plans to address these issues. In this article we revisit recent research on estimands and handling of missing values, especially the ICH E9 (R1) on Estimands and Sensitivity Analysis in Clinical Trials. Based on an in-depth discussion of the strategies for handling ICEs using a causal inference framework, we suggest some improvements in applying the estimand and estimation framework in ICH E9 (R1). Specifically, we discuss a mix of strategies allowing us to handle ICEs differentially based on reasons for ICEs. We also…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
